Evidence map›Paper›PMID 30267006›Full record

ArticleLeukemia2018

Response to "Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions" by Heidel et al.

Giovanni Barosi, Francesco Passamonti, Patrizia Accorsi, Fabrizio Pane, Alessandro M Vannucchi, Claudio Velati, Robert Peter Gale, Sante Tura, Tiziano Barbui

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Leukemia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Giovanni BarosiCenter for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy. barosig@smatteo.pv.it.
Francesco PassamontiDepartment of Medicine and Surgery, University of Insubria, ASST Sette Laghi - Ospedale di Circolo, Varese, Italy.
Patrizia AccorsiDepartment of Hematology, Transfusion Medicine and Biotechnologies, Ospedale Civile, Pescara, Italy.
Fabrizio PaneDipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Napoli, Italy.
Alessandro M VannucchiCenter for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, and Laboratorio Congiunto, University of Florence, Florence, Italy.
Claudio VelatiItalian Society of Tranfusion Medicine and Immunohematology (SIMTI), Roma, Italy.
Robert Peter GaleDepartment of Medicine, Haematology Research Centre, Division of Experimental Medicine, Imperial College London, London, UK.
Sante TuraUniversity of Bologna, Bologna, Italy.
Tiziano BarbuiClinical Research Foundation (FROM), Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Imperial College London · GBOspedale Papa Giovanni XXIII · ITPoliclinico San Matteo Fondazione · ITSocietà Italiana di Medicina Generale · ITUniversity of Bologna · ITUniversity of Florence · ITUniversity of Insubria · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Polycythemia VeraHumansHydroxyureaPhlebotomyHydroxyurea

Identifiers

PMID30267006
OpenAlexW2893599541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.